Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells

Cancer Letters

Volumn 345, Issue 1, 2014, Pages 132-139

  Guan, Jian ^a   Zhang, Hui ^a   Wen, Zhang ^a   Gu, Yumei ^a   Cheng, Yin ^a   Sun, Yang ^a   Zhang, Tingting ^a   Jia, Congwei ^a   Lu, Zhaohui ^a   Chen, Jie ^a  

^a PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

Author keywords

Cancer associated fibroblast cells; EMT; Pancreatic ductal adenocarcinoma; Retinoic acid; Tumor microenvironment; Tumor migration

Indexed keywords

CANCER ASSOCIATED FIBROBLAST CELLS; EMT; PANCREATIC DUCTAL ADENOCARCINOMA; RETINOIC ACID; TUMOR MICROENVIRONMENT; TUMOR MIGRATION;

CARCINOMA, PANCREATIC DUCTAL; CELL COMMUNICATION; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DOWN-REGULATION; EPITHELIAL-MESENCHYMAL TRANSITION; FIBROBLASTS; HUMANS; INTERLEUKIN-6; PANCREATIC NEOPLASMS; TRETINOIN;

EID: 84893736743     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2013.12.006     Document Type: Article

References (37)

1. Apte M.V., Park S., Phillips P.A., Santucci N., Goldstein D., Kumar R.K., Ramm G.A., Buchler M., Friess H., McCarroll J.A., Keogh G., Merrett N., Pirola R., Wilson J.S. Desmoplastic reaction in pancreatic cancer: role of pancreatic stellate cells. Pancreas 2004, 29:179-187.
2. Mahadevan D., Von Hoff D.D. Tumor-stroma interactions in pancreatic ductal adenocarcinoma. Mol. Cancer Ther. 2007, 6:1186-1197.
3. Hasebe T. Tumor-stromal interactions in breast tumor progression-significance of histological heterogeneity of tumor-stromal fibroblasts. Exp. Opin. Ther. Targets 2013, 17:449-460.
4. Mao Y., Keller E.T., Garfield D.H., Shen K., Wang J. Stromal cells in tumor microenvironment and breast cancer. Cancer Metast. Rev. 2013, 32:303-315.
5. Leef G., Thomas S.M. Molecular communication between tumor-associated fibroblasts and head and neck squamous cell carcinoma. Oral Oncol. 2013, 49:381-386.
6. Karagiannis G.S., Poutahidis T., Erdman S.E., Kirsch R., Riddell R.H., Diamandis E.P. Cancer-associated fibroblasts drive the progression of metastasis through both paracrine and mechanical pressure on cancer tissue. Mol. Cancer Res. 2012, 10:1403-1418.
7. Olive K.P., Jacobetz M.A., Davidson C.J., Gopinathan A., McIntyre D., Honess D., Madhu B., Goldgraben M.A., Caldwell M.E., Allard D., Frese K.K., Denicola G., Feig C., Combs C., Winter S.P., Ireland-Zecchini H., Reichelt S., Howat W.J., Chang A., Dhara M., Wang L., Ruckert F., Grutzmann R., Pilarsky C., Izeradjene K., Hingorani S.R., Huang P., Davies S.E., Plunkett W., Egorin M., Hruban R.H., Whitebread N., McGovern K., Adams J., Iacobuzio-Donahue C., Griffiths J., Tuveson D.A. Inhibition of Hedgehog signaling enhances delivery of chemotherapy in a mouse model of pancreatic cancer. Science 2009, 324:1457-1461.
8. Bachem M.G., Schünemann M., Ramadani M., Siech M., Beger H., Buck A., Zhou S., Schmid-Kotsas A., Adler G. Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells. Gastroenterology 2005, 128:907-921.
9. Kawa S., Nikaido T., Aoki Y., Zhai Y., Kumagaya T., Furihata K., Fujii S., Kiyosawa K. Arotinoid mofarotene (RO40-8757) up-regulates p21 and p27 during growth inhibition of pancreatic cancer cell lines. Int. J. Cancer 1997, 72:906-911.
10. Luesink M., Pennings J.L., Wissink W.M., Linssen P.C., Muus P., Pfundt R., de Witte T.J., van der Reijden B.A., Jansen J.H. Chemokine induction by all-trans retinoic acid and arsenic trioxide in acute promyelocytic leukemia: triggering the differentiation syndrome. Blood 2009, 114:5512-5521.
11. Pettersson F., Dalgleish A.G., Bissonnette R.P., Colston K.W. Retinoids cause apoptosis in pancreatic cancer cells via activation of RAR-gamma and altered expression of Bcl-2/Bax. Br. J. Cancer 2002, 87:555-561.
12. Thiery J.P. Epithelial-mesenchymal transitions in development and pathologies. Curr. Opin. Cell Biol. 2003, 15:740-746.
13. Sullivan N.J., Sasser A.K., Axel A.E., Vesuna F., Raman V., Ramirez N., Oberyszyn T.M., Hall B.M. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene 2009, 28:2940-2947.
14. Fernando R.I., Castillo M.D., Litzinger M., Hamilton D.H., Palena C. IL-8 signaling plays a critical role in the epithelial-mesenchymal transition of human carcinoma cells. Cancer Res. 2011, 71:5296-5306.
15. Buchholz M., Kestler H.A., Holzmann K., Ellenrieder V., Schneiderhan W., Siech M., Adler G., Bachem M.G., Gress T.M. Transcriptome analysis of human hepatic and pancreatic stellate cells: organ-specific variations of a common transcriptional phenotype. J. Mol. Med. (Berl) 2005, 83:795-805.
16. Bachem M.G., Schneider E., Gross H., Weidenbach H., Schmid R.M., Menke A., Siech M., Beger H., Grunert A., Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology 1998, 115:421-432.
17. Apte M.V., Wilson J.S. Dangerous liaisons: pancreatic stellate cells and pancreatic cancer cells. J. Gastroenterol. Hepatol. 2012, 27(Suppl 2):69-74.
18. Park J.E., Lenter M.C., Zimmermann R.N., Garin-Chesa P., Old L.J., Rettig W.J. Fibroblast activation protein, a dual specificity serine protease expressed in reactive human tumor stromal fibroblasts. J. Biol. Chem. 1999, 274:36505-36512.
19. Chi X., Anselmi K., Watkins S., Gandhi C.R. Prevention of cultured rat stellate cell transformation and endothelin-B receptor upregulation by retinoic acid. Br. J. Pharmacol. 2003, 139:765-774.
20. Massaro G.D., Massaro D. Retinoic acid treatment abrogates elastase-induced pulmonary emphysema in rats. Nat. Med. 1997, 3:675-677.
21. Wang L., Potter J.J., Rennie-Tankersley L., Novitskiy G., Sipes J., Mezey E. Effects of retinoic acid on the development of liver fibrosis produced by carbon tetrachloride in mice. Biochim. Biophys. Acta 2007, 1772:66-71.
22. Tabata C., Kadokawa Y., Tabata R., Takahashi M., Okoshi K., Sakai Y., Mishima M., Kubo H. All-trans-retinoic acid prevents radiation- or bleomycin-induced pulmonary fibrosis. Am. J. Respir. Crit. Care. Med. 2006, 174:1352-1360.
23. van Neerven S., Nemes A., Imholz P., Regen T., Denecke B., Johann S., Beyer C., Hanisch U.K., Mey J. Inflammatory cytokine release of astrocytes in vitro is reduced by all-trans retinoic acid. J. Neuroimmunol. 2010, 229:169-179.
24. Wieser F., Wu J., Shen Z., Taylor R.N., Sidell N. Retinoic acid suppresses growth of lesions, inhibits peritoneal cytokine secretion, and promotes macrophage differentiation in an immunocompetent mouse model of endometriosis. Fertil. Steril. 2012, 97:1430-1437.
25. Hsu H.C., Tsai W.H., Chen P.G., Hsu M.L., Ho C.K., Wang S.Y. In vitro effect of granulocyte-colony stimulating factor and all-trans retinoic acid on the expression of inflammatory cytokines and adhesion molecules in acute promyelocytic leukemic cells. Eur. J. Haematol. 1999, 63:11-18.
26. Shibakura M., Niiya K., Kiguchi T., Shinagawa K., Ishimaru F., Ikeda K., Namba M., Nakata Y., Harada M., Tanimoto M. Simultaneous induction of matrix metalloproteinase-9 and interleukin 8 by all-trans retinoic acid in human PL-21 and NB4 myeloid leukaemia cells. Br. J. Haematol. 2002, 118:419-425.
27. Shibakura M., Niiya K., Niiya M., Asaumi N., Yoshida C., Nakata Y., Tanimoto M. Induction of CXC and CC chemokines by all-trans retinoic acid in acute promyelocytic leukemia cells. Leuk. Res. 2005, 29:755-759.
28. Dai X., Yamasaki K., Shirakata Y., Sayama K., Hashimoto K. All-trans-retinoic acid induces interleukin-8 via the nuclear factor-kappaB and p38 mitogen-activated protein kinase pathways in normal human keratinocytes. J. Invest. Dermatol. 2004, 123:1078-1085.
29. Paland N., Kamer I., Kogan-Sakin I., Madar S., Goldfinger N., Rotter V. Differential influence of normal and cancer-associated fibroblasts on the growth of human epithelial cells in an in vitro cocultivation model of prostate cancer. Mol. Cancer Res. 2009, 7:1212-1223.
30. Lin J.T., Wang J.Y., Chen M.K., Chen H.C., Chang T.H., Su B.W., Chang P.J. Colon cancer mesenchymal stem cells modulate the tumorigenicity of colon cancer through interleukin 6. Exp. Cell Res. 2013, 319:2216-2229.
31. Endler A., Chen L., Li Q., Uchida K., Hashimoto T., Lu L., Xu G.T., Shibasaki F. Int6/eIF3e silenced HIF2alpha stabilization enhances migration and tube formation of HUVECs via IL-6 and IL-8 signaling. Cytokine 2013, 62:115-122.
32. Hassan H., Greve B., Pavao M.S., Kiesel L., Ibrahim S.A., Gotte M. Syndecan-1 modulates beta-integrin-dependent and interleukin-6-dependent functions in breast cancer cell adhesion, migration, and resistance to irradiation. FEBS J. 2013, 280:2216-2227.
33. Mano Y., Aishima S., Fujita N., Tanaka Y., Kubo Y., Motomura T., Taketomi A., Shirabe K., Maehara Y., Oda Y. Tumor-associated macrophage promotes tumor progression via STAT3 signaling in hepatocellular carcinoma. Pathobiology 2013, 80:146-154.
34. Zeisberg M., Shah A.A., Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 2005, 280:8094-8100.
35. Xie G., Yao Q., Liu Y., Du S., Liu A., Guo Z., Sun A., Ruan J., Chen L., Ye C., Yuan Y. IL-6-induced epithelial-mesenchymal transition promotes the generation of breast cancer stem-like cells analogous to mammosphere cultures. Int. J. Oncol. 2012, 40:1171-1179.
36. Korkaya H., Kim G.I., Davis A., Malik F., Henry N.L., Ithimakin S., Quraishi A.A., Tawakkol N., D'Angelo R., Paulson A.K., Chung S., Luther T., Paholak H.J., Liu S., Hassan K.A., Zen Q., Clouthier S.G., Wicha M.S. Activation of an IL6 inflammatory loop mediates trastuzumab resistance in HER2+ breast cancer by expanding the cancer stem cell population. Mol. Cell 2012, 47:570-584.
37. Venkov C., Plieth D., Ni T., Karmaker A., Bian A., George A.L., Neilson E.G. Transcriptional networks in epithelial-mesenchymal transition. PLoS One 2011, 6:e25354.